Evaluating the validity of serum neopterin and chitotriosidase levels in follow-up brucellosis patients

Internal Medicine

Volumn 49, Issue 12, 2010, Pages 1111-1118

  Coskun, Omer ^a   Oter, Sukrü ^a   Yaman, Halil ^a   Kilic, Selim ^a   Kurt, Ismail ^a   Eyigun, Can Polat ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Brucellosis; Chitotriosidase; MRI; Neopterin; Scintigraphy

Indexed keywords

CHITOTRIOSIDASE; DOXYCYCLINE; NEOPTERIN; RIFAMPICIN; STREPTOMYCIN;

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; BRUCELLOSIS; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; ENZYME BLOOD LEVEL; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; MALE; MUSCULOSKELETAL SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PROGNOSIS; PROTEIN BLOOD LEVEL; SACROILIAC JOINT; SACROILIITIS; SEROLOGY; TREATMENT DURATION; VALIDITY;

ADULT; BIOLOGICAL MARKERS; BRUCELLOSIS; DOXYCYCLINE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HEXOSAMINIDASES; HUMANS; MACROPHAGES; MALE; NEOPTERIN; REPRODUCIBILITY OF RESULTS; RIFAMPIN; STREPTOMYCIN; YOUNG ADULT;

EID: 77953966724     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.3113     Document Type: Article

References (42)

1. Corbel MJ. Brucellosis: an overview. Emerging Infectious Diseases 3: 213-221, 1997.
2. Sozen TH. Brucelloz. Infeksiyon Hastali{dotless}klari{dotless} (Infectious Diseases). Topcu AW, Soyletir G, Doganay M. Eds. Vol. 1. Nobel Ti{dotless}p Kitapevleri, Ankara, 1996: 486-493 (in Turkish with English summary)
3. Geyik MF, Gur A, Nas K, et al. Musculoskeletal involvement of brucellosis in different age groups: a study of 195 cases. Swiss Med Wkly 132: 98-105, 2002.
4. Tasova Y, Saltoglu N, Sahin G, et al. Osteoarthricular involvement of brucellosis in Turkey. Clinical rheumatology 18: 214-219, 1999.
5. Madkour MM, Kasper DL. Brucellosis. In: Harrison's Principles of Internal Medicine. Braunwald E, Hauser SL, Fauci AS, Eds. Mc Graw Hill Inc, New York, 2001: 986-989.
6. Young EJ. Brucella species. In: Principles and Practice of Infectious Disease. 6th Ed. Mandel GL, Bennet JE, Dolin R, Eds. Churchill Livingstone, Philedelphia, USA, 2005: 2669-2674.
7. Golding B, Scott DE, Scharf O, et al. Immunity and protection against Brucella abortus. Microbes Infect 3: 43-48, 2001.
8. Hamerlinck FF. Neopterin: a review. Exp Dermatol 8: 167-176, 1999.
9. Hoffmann G, Wirleitner B, Fuchs D. Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res 52: 313-321, 2003.
10. Buhrer-Sekula S, Hamerlinck FF, Out TA, Bordewijk LG, Klatser PR. Simple dipstick assay for semi-quantitative detection of neopterin in sera. J Immunol Methods 238: 55-58, 2000.
11. Renkema GH, Boot RG, Strijland A, et al. Synthesis, sorting, and processing into distinct isoforms of human macrophage chitotriosidase. Eur J Biochem 244: 279-285, 1997.
12. Giraldo P, Cenarro A, Alfonso P, et al. Chitotriosidase genotype and plasma activity in patients type 1 Gaucher's disease and their relatives (carriers and non carriers). Haematologica 86: 977-984, 2001.
13. Casal JA, Lacerda L, Perez LF, Pinto RA, Clara Sa Miranda M. Carlos Tutor J. Relationships between serum markers of monocyte/macrophage activation in type 1 Gaucher's disease. Clin Chem Lab Med 40: 52-55, 2002.
14. Barone R, Di Gregorio F, Romeo MA, Schiliro G, Pavone L. Plasma chitotriosidase activity in patients with beta-thalassemia. Blood Cells Mol Dis 25: 1-8, 1999.
15. Maccarone C, Pizzarelli G, Barone R, Musumeci S. Plasma chitotriosidase activity is a marker of recovery in transplanted patients affected by beta-thalassemia major. Acta Haematol 105: 109-110, 2001.
16. Barone R, Simpore J, Malaguarnera L, Pignatelli S, Musumeci S. Plasma chitotriosidase activity in acute Plasmodium falciparum malaria. Clin Chim Acta 331: 79-85, 2003.
17. Labadaridis J, Dimitriou E, Costalos C, et al. Serial chitotriosidase activity estimations in neonatal systemic candidiasis. Acta Paediatr 87: 605, 1998.
18. Young EJ. Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature. Reviews of Infectious Diseases 13: 359-372, 1991.
19. Gul HC, Coskun O, Turhan V, et al. Brucellosis: retrospective investigation of 140 patients. TAF Preventive Medicine Bulletin 6: 249-252, 2007.
20. Serra J, Vinas M. Laboratory diagnosis of brucellosis in a rural endemic area in northeastern Spain. Int Microbiol 7: 53-58, 2004.
21. Memish ZA, Almuneef M, Mah MW, Qassem LA, Osoba AO. Comparison of the Brucella Standard Agglutination Test with the ELISA IgG and IgM in patients with Brucella bacteremia. Diagn Microbiol Infect Dis 44: 129-132, 2002.
22. Buchanan TM, Faber LC. 2-mercaptoethanol Brucella agglutination test: usefulness for predicting recovery from brucellosis. Journal of Clinical Microbiology 11: 691-693, 1980.
23. Bosilkovski M, Krteva L, Caparoska S, Dimzova M. Osteoarticular involvement in brucellosis: study of 196 cases in the Republic of Macedonia. Croat Med J 45: 727-733, 2004.
24. Fuchs D, Weiss G, Wachter H. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol 101: 1-6, 1993.
25. Tunc T, Kul M, Yaman H, et al. Chitotriosidase activity in human milk from mothers of premature and full-term infants during the first month of lactation. Clin Biochem 41: 693-696, 2008.
26. Alton GG, Jones LM, Pietz DE. Laboratory techniques in brucellosis. Monogr Ser World Health Organ 55: 1-163, 1975.
27. Orduna A, Almaraz A, Prado A, et al. Evaluation of an immunocapture-agglutination test (Brucellacapt) for serodiagnosis of human brucellosis. J Clin Microbiol 38: 4000-4005, 2000.
28. Young EJ. An overview of human brucellosis. Clin Infect Dis 21: 283-289; quiz 290, 1995.
29. Gotuzzo E, Alarcon GS, Bocanegra TS, et al. Articular involvement in human brucellosis: a retrospective analysis of 304 cases. Semin Arthritis Rheum 12: 245-255, 1982.
30. Mousa AR, Muhtaseb SA, Almudallal DS, Khodeir SM, Marafie AA. Osteoarticular complications of brucellosis: a study of 169 cases. Rev Infect Dis 9: 531-543, 1987.
31. Iwagaki H, Hizuta A, Tanaka N, et al. Plasma neopterin/C-reactive protein ratio as an adjunct to the assessment of infection and cancer cachexia. Immunol Invest 24: 479-487, 1995.
32. Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 9: 532-562, 1996.
33. Fuchs D, Norkrans G, Wejstal R, et al. Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2b. Eur J Med 1: 196-200, 1992.
34. Sheldon J, Riches PG, Soni N, et al. Plasma neopterin as an adjunct to C-reactive protein in assessment of infection. Clin Chem 37: 2038-2042, 1991.
35. Akbulut HH, Celik I, Akbulut A, et al. Serum neopterin levels in patients with brucellosis. J Infect 51: 281-286, 2005.
36. Bouzas L, Carlos Guinarte J, Carlos Tutor J. Chitotriosidase activity in plasma and mononuclear and polymorphonuclear leukocyte populations. J Clin Lab Anal 17: 271-275, 2003.
37. Labadaridis I, Dimitriou E, Theodorakis M, et al. Chitotriosidase in neonates with fungal and bacterial infections. Arch Dis Child 90: F531-F532, 2005.
38. Colmenero JD, Reguera JM, Frenandez-Nebro A, Cabrera Franquelo F. Osteoarticular complications of brucellosis. Ann Rheum Dis 50: 23-26, 1991.
39. al-Eissa YA, Kambal AM, Alrabeeah AA, et al. Osteoarticular brucellosis in children. Ann Rheum Dis 49: 896-900, 1990.
40. Johnson K, Gardner-Medwin J. Childhood arthritis: classification and radiology. Clin Radiol 57: 47-58, 2002.
41. Cohen PA, Job-Deslandre CH, Lalande G, et al. Overview of the radiology of juvenile idiopathic arthritis (JIA). Eur J Radiol 33: 94-101, 2000.
42. Wittram C, Whitehouse GH. Normal variation in the magnetic resonance imaging appearances of the sacroiliac joints: pitfalls in the diagnosis of sacroiliitis. Clin Radiol 50: 371-376, 1995.